<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002422.ref052">
 <label>52</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Grant</surname>
   <given-names>RM</given-names>
  </name>, 
  <name>
   <surname>Sevelius</surname>
   <given-names>JM</given-names>
  </name>, 
  <name>
   <surname>Guanira</surname>
   <given-names>JV</given-names>
  </name>, 
  <name>
   <surname>Aguilar</surname>
   <given-names>JV</given-names>
  </name>, 
  <name>
   <surname>Chariyalertsak</surname>
   <given-names>S</given-names>
  </name>, 
  <name>
   <surname>Deutsch</surname>
   <given-names>MB</given-names>
  </name>. 
  <article-title>Transgender women in clinical trials of pre-exposure prophylaxis</article-title>. 
  <source>J Acquir Immune Defic Syndr</source>. 
  <year>2016</year>;
  <volume>72</volume>(
  <issue>Suppl 3</issue>):
  <fpage>S226</fpage>â€“
  <lpage>9</lpage>. 
  <comment>doi: 
   <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/qai.0000000000001090" xmlns:xlink="http://www.w3.org/1999/xlink">10.1097/qai.0000000000001090</ext-link>
  </comment>
  <?supplied-pmid 27429187?>
  <pub-id pub-id-type="pmid">27429187</pub-id>
 </mixed-citation>
</ref>
